Published: April 2014
Roots Analysis has announced the addition of the “Single-use Bioreactors, 2014-2024” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of single-use bioreactors in the coming decade.
In addition to the market forecasts, the report clearly identifies the various challenges and opportunities in the short and long term. It provides a comprehensive analysis of the market including profiles of ten established and emerging companies. Mayank Kaura, the lead analyst, said, “Single-use bioreactors are already being deployed for high density cell culture applications (monoclonal antibodies, recombinant proteins, vaccines etc.). Newer application areas being researched include stem cells and personalised medicine.”
“We identified 17 manufacturers offering around 80-90 models of single-use bioreactors with working volumes ranging from as low as few millilitres to up to 2000L. Quite recently, many start-ups have sprung up. Examples include CerCell, PBS Biotech, Cellexus Limited; these start-ups have launched single-use bioreactors with innovative features and are likely to play an increasingly important role in the future.”
By 2024, the single-use bioreactor market is expected to grow close to USD 1 billion. Emergence of new technologies is likely to provide the necessary impetus to fuel future growth. The detailed study provides insights on the recent manufacturing collaborations and mergers / acquisitions which are rapidly changing the market landscape. Key topics covered in the report are:
Who should buy this report?
This research is targeted towards big / small pharmaceutical companies and contract manufacturers which are working in the field of drug delivery and development. In particular, you could benefit from this report if you are looking to:
For sample pages, to request Executive Summary or to order the full report, please send an email to firstname.lastname@example.org
About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at email@example.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry